Masahiro Yasunaga

Chief

National Cancer Center

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (5)

Eita Sasaki

Senior Assistant Professor / Lecturer

Keio University

JAPAN

View details

Takuya Shiraishi

Gunma University Hospital

JAPAN

View details

Takahiro Anzai

Assistant Professor

National Institute of Technology, Gunma College

JAPAN

View details

Ryutaro Asano

Tokyo University of Agriculture and Technology

JAPAN

View details

Shino Manabe

Professor

Hoshi University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Masahiro Yasunaga

Research Interests

Explore related searches

Contact this professor

Articles (10)

Tumor Targeting of <sup>211</sup>At-Labeled Antibody under Sodium Ascorbate Protection against Radiolysis

Chromatographic Analysis of the N-Glycan Profile on Therapeutic Antibodies Using FcγRIIIa Affinity Column Chromatography

Expansion of mixed immune cells using CD3/CD161 co-stimulation for the treatment of cancer

Quantitative analysis of drug distribution in heterogeneous tissues using dual‐stacking capillary electrophoresis–mass spectrometry

Protection from contamination by <sup>211</sup>At, an enigmatic but promising alpha-particle-emitting radionuclide

Identification of CD73 as the Antigen of an Antigen-Unknown Monoclonal Antibody Established by Exosome Immunization, and Its Antibody–Drug Conjugate Exerts an Antitumor Effect on Glioblastoma Cell Lines

Evaluation of Fluorescence Intensity and Antitumor Effect Using Real-Time Imaging in Photoimmunotherapy

Molecular design of near-infrared (NIR) fluorescent probes targeting exopeptidase and application for detection of dipeptidyl peptidase 4 (DPP-4) activity

High expression of TMEM180, a novel tumour marker, is associated with poor survival in stage III colorectal cancer.

T Cell Bispecific Antibodies: An Antibody-Based Delivery System for Inducing Antitumor Immunity

Collaborators (5)

Eita Sasaki

Takuya Shiraishi

Takahiro Anzai

Ryutaro Asano

Shino Manabe

Make your next move.